Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
942.55
3.35 (0.36%) Cadila Healthcare to consider unaudited financial results
Date: 16-01-2013Cadila Healthcare has informed that a meeting of the board of directors of the company will be held on February 08, 2013, to consider unaudited financial results for the quarter/nine months ended on December 31, 2012.
The above information is a part of company’s filings submitted to BSE.